ArticleHaematologica2022

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017.

Alexandra Albertsson-Lindblad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.